Marshall Wace’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
Other funds holding CNMD
ICM
Marshall Wace's CNMD Position: Q2 2026 in Review
Marshall Wace increased its CONMED (CNMD) stake by 2.8% in Q2 2026, buying an estimated $169K and bringing the position to 175,454 shares worth $5.74M. The position accounts for ﹤0.01% of the portfolio, ranked #1297.
Marshall Wace first reported a position in CNMD in Q2 2014 and has held it in 17 quarters since. The position peaked at $33.2M in Q1 2019. 247 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.
- Marshall Wace held 175,454 shares of CONMED worth $5.74M as of Q2 2026.
- Marshall Wace bought 4,698 CONMED shares in Q2 2026, an estimated $169K.
- CONMED made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #1297 holding.
- Marshall Wace first reported a position in CONMED in Q2 2014 and has held it in 17 quarters since.
- Marshall Wace's CONMED position peaked at $33.2M in Q1 2019.
- 247 funds tracked by Wall St. Rank held CONMED as of Q2 2026.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.